
Curaleaf today announced that it has acquired the equity stake in Curaleaf International Holdings previously held by a single strategic institutional investor. The transaction brings the Company's stake in its European holding company to 100%.
The transaction represents the completion of a put/call option that was agreed with the strategic investor at the time of its participation in Curaleaf's original investment into Europe in 2021. Following the pricing mechanism incorporated in the put/call option, the investor elected to receive the purchase entirely in Curaleaf subordinate voting shares.
Curaleaf said the acquisition strengthens its control over its European operations, enabling enhanced strategic alignment across international markets. The request of the strategic investor to settle the transaction for company shares underscores the investor's long-term support and confidence in the future of Curaleaf.
"This consolidation of ownership of our European holding company enables us to streamline decision-making, strengthen alignment across regions, and accelerate our strategic initiatives in Europe with greater autonomy. This development marks another important milestone in Curaleaf's continued commitment to international expansion and long-term value creation for shareholders. We thank our partners for their long-standing support and belief in Curaleaf's future," said Curaleaf CEO Boris Jordan in a statement.